A Study to Collect Surgical Tumor Samples for Prostate Cancer-derived Tissue Graft

Overview

About this study

The purposes of this study are to collect prostate surgical samples from metastatic patients to establish xenograft tumor lines for future testing of potential therapies and for understanding mechanisms of therapy resistance via DNA/RNA sequencing, to collect patient blood samples for future DNA/RNA sequencing , and to collect patient urine samples for future prostate cancer related biomarker detection and DNA/RNA sequencing.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Males, 18 years of age or older.
  • Metastatic Prostate Cancer (lymph node-positive metastatic prostate cancer).

Exclusion Criteria: 

  • Life expectancy of less than 3 months.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Liewei Wang, M.D., Ph.D.

Open for enrollment

Contact information:

Kathryn Barthels B.S.

(507) 538-5772

Barthels.Kathryn@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20480304

Mayo Clinic Footer